Astria Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Astria Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2014 to Q3 2024.
  • Astria Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.48M, a 78.6% increase year-over-year.
  • Astria Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $16.1M, a 92.5% increase year-over-year.
  • Astria Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.1M, a 507% increase from 2022.
  • Astria Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.67M, a 2508% increase from 2021.
  • Astria Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $64K, a 52.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $16.1M $4.48M +$1.97M +78.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $14.2M $4.63M +$2.1M +82.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $12.1M $4.22M +$1.92M +83.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.1M $2.79M +$1.76M +172% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 $8.38M $2.51M +$2.12M +545% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $6.26M $2.54M +$2.34M +1174% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $3.92M $2.31M +$2.25M +4091% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.67M $1.03M +$1.01M +6313% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 $659K $389K +$362K +1341% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $297K $199K +$179K +895% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $118K $55K +$54K +5400% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $64K $16K +$17K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $47K $27K +$26K +2600% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $21K $20K -$25K -55.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $46K $1K -$89K -98.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $135K -$1K -$138K -101% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $273K $1K -$167K -99.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $440K $45K -$149K -76.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $589K $90K -$206K -69.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $795K $137K +$109K +389% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 $686K $168K -$161K -48.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $847K $194K +$37K +23.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $810K $296K +$309K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $501K $28K +$63K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $438K $329K +$394K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $44K $157K +$212K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$168K -$13K +$102K +88.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$270K -$35K +$70K +66.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$340K -$65K +$71K +52.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$411K -$55K -$6K -12.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$405K -$115K +$97K +45.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$502K -$105K +$167K +61.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$669K -$136K +$148K +52.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$817K -$49K +$226K +82.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$1.04M -$212K -$72K -51.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$971K -$272K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$284K -$229K -416% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$275K -$276K -27600% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$140K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 -$55K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $1K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.